Cleared Traditional

MRopen 0.5 T (K190524) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K190524 · Asg Superconductors S.P.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
119d
Days
Class 2
Risk

K190524 is an FDA 510(k) clearance for the MRopen 0.5 T. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Asg Superconductors S.P.A. (Genova, IT). The FDA issued a Cleared decision on July 1, 2019 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Asg Superconductors S.P.A. devices

Submission Details

510(k) Number K190524 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2019
Decision Date July 01, 2019
Days to Decision 119 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 107d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 498
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K190524.
Signa Voyager, Signa Voyager Quantum
K192426 · Ge Healthcare (Tianjin) Company Limited · Oct 2019
Vantage Orian 1.5T, MRT-1550, V4.5
K191662 · Canon Medical Systems Corporation · Jul 2019
MAGNETOM Aera and MAGNETOM Skyra with Software syngo MR E11E with Ischemic Heart Disease (IHD) Workflow
K191050 · Siemens Medical Solutions USA, Inc. · Jul 2019
LiverMultiScan (LMSv3)
K190017 · Perspectum Diagnostics, Ltd. · Jun 2019
Vantage Titan 3T, MRT-3010, V2.5
K191128 · Canon Medical Systems Corporation · Jun 2019
SyMRI
K191036 · Syntheticmr AB · Jun 2019